Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more

TSX:PRN - Post Discussion

Profound Medical Corp > Raymond James
View:
Post by retiredcf on Dec 11, 2020 7:37am

Raymond James

10 Dec 2020
Profound Medical Corp. (PRN.T)
Target Set by Raymond James (C$22.97) C$43.00 Strong-Buy
Comment by Charlie263 on Dec 11, 2020 8:53am
What is source of this news? please share the link.
Comment by wobbles on Dec 20, 2020 12:32pm
Raymond James simply reiterated their analysis and forecast. You can see it here https://www.marketbeat.com/ratings/by-issuer/raymond-james-stock-recommendations/
Comment by MrMugsy on Dec 12, 2020 1:00pm
I am assuming, to get some real traction here, we need to start adding locations a little faster - maybe a first in Canada to get Knight buiding in parallel. From the last conference call, it doesn't look like we're done adding in 2020. Fingers crossed.
Comment by retiredcf on Dec 13, 2020 7:39am
It was on Marketbeat so there's no report. If there's a RJ client on this BB, perhaps they could post it. GLTA
Profound Medical Corp